About the Authors
- Jonas Christian Schupp
-
Affiliation Department of Pneumology, University Medical Centre, Freiburg, Germany
- Harald Binder
-
Affiliation Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University, Mainz, Germany
- Benedikt Jäger
-
Affiliations Department of Pneumology, University Medical Centre, Freiburg, Germany, Faculty of Biology, University of Freiburg, Freiburg, Germany
- Giuseppe Cillis
-
Affiliation Respiratory Diseases Section, Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy
- Gernot Zissel
-
Affiliation Department of Pneumology, University Medical Centre, Freiburg, Germany
- Joachim Müller-Quernheim
-
Affiliation Department of Pneumology, University Medical Centre, Freiburg, Germany
- Antje Prasse
-
* E-mail: antje.prasse@uniklinik-freiburg.de
Affiliation Department of Pneumology, University Medical Centre, Freiburg, Germany
Competing Interests
JMQ, AP and GZ have a patent EP 2011/060641 24.06.2011 “Blockade of CCL18 signalling via CCR6 as a therapeutic option in fibrotic diseases and cancer” pending. AP received lecture fees from Intermune, Boehringer Ingelheim and consultancy fees for Novartis, Aventis-Sanofi. Antje Prasse and Gernot Zissel are PLOS ONE Editorial Board members. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. All other authors report no conflicts of interest.
Author Contributions
Conceived and designed the experiments: JCS JMQ AP. Performed the experiments: JCS BJ GC. Analyzed the data: JCS HB AP. Contributed reagents/materials/analysis tools: HB GZ JMQ AP. Wrote the paper: JCS HB JMQ GZ AP.